Chong Xu

Chong Xu

Director/Board Member chez K36 Therapeutics, Inc.

43 ans
Finance
Health Technology
Consumer Services

Profil

Chong Xu is currently a Director at Geneception, Inc., K36 Therapeutics, Inc., Shanghai Rarestone Health Tech Group Co. Ltd., and Partner at Impresa Management LLC.
Previously, Dr. Xu worked as a Director at Adagene, Inc. from 2020 to 2021, an Equity Analyst at Massif Partners Holdings LP, an Associate at McKinsey & Co., Inc., an Analyst at Affirmed Capital LLC, and a Principal at Eight Roads Ventures Japan.
Dr. Xu holds a doctorate degree from the University of Virginia, an undergraduate degree from Zhejiang University, and an MBA from the University of Virginia Darden School of Business.

Postes actifs de Chong Xu

SociétésPosteDébut
Private Equity Investor -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Tous les postes actifs de Chong Xu

Anciens postes connus de Chong Xu

SociétésPosteFin
ADAGENE INC. Director/Board Member 08/02/2021
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Analyst-Equity -
Voir l'expérience en détail de Chong Xu

Formation de Chong Xu

University of Virginia Doctorate Degree
Zhejiang University Undergraduate Degree
University of Virginia Darden School of Business Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Chong Xu

Relations

100 +

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
ADAGENE INC.

Health Technology

Entreprise privées8

Finance

Commercial Services

Finance

Finance

Finance

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés